Stay updated on Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    6 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-13T23:15:30.000Z thumbnail image
  6. Check
    13 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update regarding the Data Monitoring Committee (DMC) in a study related to the efficacy and safety of a combination treatment for metastatic castration-resistant prostate cancer.
    Difference
    0.0%
    Check dated 2024-06-06T14:52:36.000Z thumbnail image
  7. Check
    28 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying conditions such as confirmed adenocarcinoma of the prostate and progression during androgen deprivation therapy. Previously, this section only indicated that no information was provided.
    Difference
    18%
    Check dated 2024-05-22T21:26:03.000Z thumbnail image
  8. Check
    50 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T21:55:44.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Olaparib vs Abiraterone in mCRPC Clinical Trial page.